Skip to main content

Laia Rubio Ortega

Institutions of which they are part

Research technician
Gene Therapy at Nervous System
Vall Hebron Institut de Recerca

Laia Rubio Ortega

Institutions of which they are part

Research technician
Gene Therapy at Nervous System
Vall Hebron Institut de Recerca

Projects

ESTUDIO Y DESARROLLO DE LA PRIMERA PLATAFORMA TECNOLÓGICA DE ENSAYOS PARA VIRUS ADENOASOCIADOS EN TERÁPIA GÉNICA

IP: Miguel Chillon Rodriguez
Collaborators: Susana Miravet Delgado, Laia Rubio Ortega, Marina Tarrés Mercader, Almudena Sanchez Garcia
Funding agency: Instituto de Salud Carlos III
Funding: 296571
Reference: PMPTA22/00048
Duration: 01/01/2023 - 30/06/2025

Related news

The European Rare Diseases Research Alliance (ERDERA) kicked off this September, with an estimated budget of 380 million euros and the aim of improving the lives of 30 million rare disease patients in Europe and beyond.

This gene therapy protects mice against cognitive deficits associated with aging, improves motor function, and delays the onset of diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease.

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.

Related professionals

Laura Rodriguez Estévez

Laura Rodriguez Estévez

Postdoctoral researcher
Gene Therapy at Nervous System
Read more
Amaia Latasa Arrazubi

Amaia Latasa Arrazubi

Medium Grade Technician
Academic Research Organisation (ARO)
Clinical Core Facilities
External Strategy Directorate
Read more
Iñigo Royo Crespo

Iñigo Royo Crespo

Senior researcher
General Surgery
Read more
Monica Kruger

Monica Kruger

Research technician
Pneumology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.